June 2017
Financial Advisor to Company on its §363 sale to Murray Enterprises, LLC and S3 Ventures, LLC
Financial Advisor to Neuronetics on its Announced Merger with Greenbrook TMS
Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
Exclusive Financial Advisor (Buy side)
